Anti-Human HLA-DRB Recombinant Antibody
-
Product Number
YR1018
-
Alias
科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab
-
Specifications
- 1mg
- 5mg
YR1018
科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab
| Alias | 科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab |
| Catalog Number | YR1018 |
| Molecular Name | Apolizumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 |
| Formulation | PBS, pH7.5 |
| Background | Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use. |
| CAS Number | 267227-08-7 |
| Application | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | HLA-DRB[Homo sapiens] |
0